Published in BMJ 2026; 392 (doi: 10.1136/bmj-2025-086384), this research examined whether long-term PPI use is associated with an increased risk of gastric adenocarcinoma. The findings suggest that long-term use of PPIs may not be linked to stomach cancer, offering important insights for patients and healthcare providers alike.

